¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Matrix Attachment Regions"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • nail matrix
    ¼Õ¹ßÅé¹ÙÅÁÁú, Á¶°©±âÁú
  • variance matrix
    ºÐ»êÇà·Ä
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • matrix interference
    ±âÁú°£¼·
  • matrix
    ¹ÙÅÁÁú, ±âÁú
  • matrix mechanics
    Çà·Ä¿ªÇÐ
  • matrix number
    Çà·Ä¼ö
  • matrix protein
    ¹ÙÅÁÁú´Ü¹é
  • mesangial matrix
    Ç÷°ü»çÀ̹ÙÅÁÁú
  • mitochondrial matrix
    »ç¸³Ã¼¹ÙÅÁÁú
  • nail matrix
    ¼Õ¹ßÅé¹ÙÅÁÁú
  • organic matrix
    À¯±â¹ÙÅÁÁú
  • similarity matrix
    Çà·Ä½ÄÀ¯»çµµ°Ë»ç
  • spring fixed matrix
    ź·Â°íÁ¤´ë»ó°Ýº®
  • territorial matrix
    ¿µ¿ª¹ÙÅÁÁú
  • variance matrix
    ºÐ»êÇà·Ä
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • searching behavior, of attachment loss
    Ž»öÇൿ(¾ÖÂø»ó½Ç¿¡¼­)
  • soldering attachment
    ³³Âø¹ý(ÕÄó·Ûö).
  • split pin and tube attachment
    À¯ÃʺÐÇÒÇÕÁ¤(êóõ¦ÝÂùÜùêïù).
  • superficial attachment
    Ç¥¸éºÎÂø
  • acquisition matrix number
    ȹµæ Çà·Ä ¼ö, ȹµæ ¸ÅÆ®¸¯½º ¼ö
  • amalgam matrix
    ÇÕ±ÝÁÖÇü(ùêÐÝñÑúþ).
  • band matrix
    ´ë»ó°Ýº®(ÓáßÒ̰Ûú).
  • bone matrix
    »À ±âÁú, °ñ ±âÁú(ÍéÐñòõ).
  • bone matrix
    »À±âÁú, °ñ±âÁú(ÍéÐñòõ).
  • bone matrix
    »À¹ÙÅÁÁú
  • cartilage matrix
    ¿¬°ñ¹ÙÅÁÁú
  • cell adhesive matrix assay
    ¼¼Æ÷Á¡Âø±âÁúºÐ¼®
  • cell matrix
    ¼¼Æ÷±âÁú
  • chromosome matrix
    ¿°»öü±âÁú(¡­Ñ¨òõ).
  • crest of matrix
    ¹ÙÅÁÁú´É¼±
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
GMH germinal matrix hemorrhage
GMRH germinal matrix related hemorrhage
MMP matrix metalloproteinase; muscle mechanical power
MMPI matrix metalloproteinase specific for collagen type I; Minnesota Multiphasic Personality Inventory
MP macrophage; matrix protein; mean pressure; melphalan and prednisone; melting point; membrane potenti...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PAL Probing Attachment Level
SNAP soluble NSF attachment protein
att attachment
AL attachment loss
CAL clinical attachment loss
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fibrous attachment
    ¼¶À¯¼º ºÎÂø
  • frictional attachment
    ¸¶ÂûÇü ¾îÅÂÄ¡¸ÕÆ®
  • Inoue attachment
    À̳ë¿ì ¾îÅÂÄ¡¸ÕÆ®
    °¡µ¿ºÎ¿Í °íÁ¤ºÎ¿ÍÀÇ ¿¬°áÀ» ÇÉÀ¸·Î ºÙÀÌ´Â Çü½ÄÀ¸·Î µÇ¾î ÀÖ´Ù. ±¹¼Ò ÀÇÄ¡¿¡ »ç¿ëµÈ´Ù.
  • interlock attachment
    °¨ÇÕ ºÎ°¡ ÀåÄ¡
    °íÁ¤ ¸ñÀû°ú ÆòÇàÇÏÁö ¾ÊÀº Áö´ëÄ¡¿¡ »ç¿ëµÇ´Â ºñ¸¶Âû¼ºÀÇ T ÀÚÇüÀÇ ºÎ°¡ ÀåÄ¡ÀÌ´Ù.
  • ligamentous attachment
    Àδ뼺 ºÎÂø¹°
  • male attachment
    ¿õ¼º ºÎ°¡ ÀåÄ¡
    À½Çü ºÎ°¡ ÀåÄ¡¿¡ ÀûÇÕÇϵµ·Ï µ¹ÃâµÈ ºÎ°¡ ÀåÄ¡ÀÌ´Ù.
  • Morgan attachment
    ¸ð¸£°£ ºÎ°¡ ÀåÄ¡
  • Muller attachment
    ¹Ä·¯ ºÎ°¡ ÀåÄ¡
  • Omega attachment

    omemtulum

    Omenns syndrome : µ¿ÀǾî=histiocytic medullary reticulosis.

    omental

    ´ë¸ÁÀÇ
  • parallel attachment
    Á¤¹Ð ¾îÅÂÄ¡¸ÕÆ®, ÆòÇà ºÎ°¡ ÀåÄ¡
    ¿õ¼º°ú ¿ä¼º °£ÀÇ ÆòÇà °ü°è¿¡¼­ ¿À´Â ÀúÇ×À» ÀÌ¿ëÇÑ ÇüÅÂÀÌ´Ù.
  • precision attachment
    Á¤¹Ð ¾îÅÂÄ¡¸ÕÆ®, Á¤¹Ð ºÎ°¡ ÀåÄ¡
  • precision type attachment
    Á¤¹ÐÇü ºÎÂø ÀåÄ¡
  • Scott attachment
    ½ºÄÚÆ® ºÎ°¡ ÀåÄ¡
    °íÁ¤ ¹× °¡Ã¶¼º ÀÇÄ¡¿¡¼­ »ç¿ëµÇ¸ç, ¼öÆò ¾Ï
  • Scott external precision attachment
    ½ºÄÚÆ® ºÎ°¡ ÀåÄ¡
    °íÁ¤ ¹× °¡Ã¶¼º ÀÇÄ¡¿¡¼­ »ç¿ëµÇ¸ç, ¼öÆò ¾Ï
  • semi-precious attachment
    ¹Ý Á¤¹ÐÇü ºÎ°¡ ÀåÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
regions of upper limb The topographic divisions of the upper limb: deltoid, arm, elbow, forearm, carpal region, and hand.
Synonym: regiones membri superioris, regions of superior limb.
(05 Mar 2000)
regulatory regions or sequences A DNA base sequence that controls gene expression.
(05 Mar 2000)
complementarity determining regions That part of an antibody or T-cell receptor variable region that binds with antigen or antigen/major histocompatibility molecule.
(05 Mar 2000)
promoter regions <genetics> DNA sequences which are recognised (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the pribnow box in bacteria and the tata box in eukaryotes.
(12 Dec 1998)
scaffold-associated regions Sites in DNA that bind topoisomerase II and other scaffold proteins; found in introns.
(05 Mar 2000)
hypervariable regions The regions of the immunoglobulin molecule that contain most of the residues involved in the antibody binding site.
(05 Mar 2000)
terminator regions (genetics) DNA sequences which signal the termination of transcription.
(12 Dec 1998)
amalgam matrix A device used during placement of the amalgam mass within a compound cavity preparation, facilitating proper condensation and contour thereof by providing a confining wall.
(05 Mar 2000)
bone matrix The intercellular substance of bone tissue consisting of collagen fibres, ground substance, and inorganic bone salts.
(05 Mar 2000)
cartilage matrix The intercellular substance of cartilage consisting of fibres and ground substance.
(05 Mar 2000)
matrix Ground substance in which things are embedded or that fills a space (as for example the space within the mitochondrion). most common usage is for a loose meshwork within which cells are embedded (e.g. Extracellular matrix), although it may also be used of filters or absorbent material.
(18 Nov 1997)
matrix-associated helicase <enzyme> Component of the pre-mRNA splicing complex; has atpase activity and DNA helicase activity on a partially double-stranded DNA substrate in the 3'-5' direction
Registry number: EC 2.7.7.-
Synonym: helicase mah
(26 Jun 1999)
matrix band A metal or plastic band secured around the crown of a tooth to confine restorative material to be adapted into a prepared cavity.
(05 Mar 2000)
matrix bands Devices which provide an artificial temporary wall, or matrix, used in filling a prepared cavity.
(12 Dec 1998)
matrix calculi <radiology> Radiolucent, associated with Proteus infection, composition: 2/3 mucoprotein, 1/3 mucopolysaccharide see also: renal calculi
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á